New HPV shot covers a wider range of cancers. Make sure your adolescent gets it
health.harvard.edu
health.harvard.edu
Sponsor: Merck Sharp & Dohme Corp
Official Title: A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26- Year-Old Women
Health Authority: United States: Food and Drug Administration